Adrian Gottschalk
Förmögenhet: 3 M $ per 2026-08-31
Förmögenhet: 3 M $ per 2026-08-31
Adrian Gottschalk is President, Chief Executive Officer & Director at Foghorn Therapeutics, Inc. since 2017.
Formerly, Mr. Gottschalk was SVP & Head-Neurodegeneration Therapeutic Area at Biogen, Inc. from 2015 to 2017.
Education includes an undergraduate degree from Texas A&M University in 1997, an MBA from MIT Sloan School of Management in 2003, and a graduate degree from Harvard Medical School in 2004.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-20 | 511 704 ( 0,87 % ) | 3 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Verkställande Direktör | 2017-05-01 |
| Företag | Position | Slut |
|---|---|---|
| BIOGEN INC. | Företagsledare/Principal | 2017-05-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foghorn Therapeutics, Inc.
Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån